- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Diagnostic Kits
OraSure Technologies Inc
+ Add to WatchlistOSUR:US
4.4100 USD 0.0600 1.38%As of 16:30:00 ET on 05/23/2013.
Snapshot for OraSure Technologies Inc (OSUR)
| Open: | 4.3100 | Day's Range: | 4.2600 - 4.4300 | Volume: | 248,686 |
|---|---|---|---|---|---|
| Previous Close: | 4.3500 | 52wk Range: | 4.2400 - 14.0100 | 1-Yr Rtn: | -57.68% |
Key Statistics for OSUR
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -0.4000 |
| Est. EPS (USD) (12/2013) | -0.5410 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 244.89 |
| Shares Outstanding (M) | 55.53 |
| 30 Day Average Volume | 420,360 |
| Price/Book (mrq) | 1.5313 |
| Price/Sale (ttm) | 2.6602 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/07/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for OSUR
Company Profile & Key Executives for OSUR
OraSure Technologies, Inc. develops, manufactures, and markets medical devices and diagnostic products. The Company supplies oral fluid collection devices and assays to the life insurance industry and public health markets for the detection of antibodies to HIV. OraSure also supplies oral fluid testing solutions for drugs-of-abuse testing.
| Douglas A MichelsPresident/CEO | Ronald H SpairCFO/COO |
| Stephen R LeeExec VP/Chief Science Officer | Anthony Zezzo IIExec VP:Marketing & Sales |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
OSUR News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page